The role of enamel matrix derivative protein in minimally invasive surgery in treating intrabony defects in single-rooted teeth: A randomized clinical trial

Journal of Periodontology

Volumn 82, Issue 4, 2011, Pages 522-532

  Ribeiro, Fernanda V ^a   Casarin, Renato C V ^a   Junior, Francisco H N ^a   Sallum, Enilson A ^a   Casati, Márcio Z ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Microsurgery; Minimal surgical procedures; Periodontal diseases; Regeneration

Indexed keywords

ENAMEL MATRIX PROTEINS; ENAMEL PROTEIN;

ADULT; ALVEOLAR BONE LOSS; ARTICLE; BONE PROSTHESIS; BONE REGENERATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GINGIVITIS; HUMAN; LONGITUDINAL STUDY; MALE; METHODOLOGY; MIDDLE AGED; MINIMALLY INVASIVE SURGERY; PERIODONTAL DISEASE; PHYSIOLOGY; PROSPECTIVE STUDY; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TOOTH ROOT; TREATMENT OUTCOME;

ADULT; ALVEOLAR BONE LOSS; BONE REGENERATION; BONE SUBSTITUTES; DENTAL ENAMEL PROTEINS; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PERIODONTAL ATTACHMENT LOSS; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TOOTH ROOT; TREATMENT OUTCOME;

EID: 79955025438     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2010.100454     Document Type: Article

References (45)

1. Mellonig JT. Enamel matrix derivative for periodontal reconstructive surgery: Technique and clinical and histologic case report. Int J Periodontics Restorative Dent 1999;19:8-19.
2. Yukna RA, Mellonig JT. Histologic evaluation of periodontal healing in humans following regenerative therapy with enamel matrix derivative. A 10-case series. J Periodontol 2000;71:752-759.
3. Esposito M, Grusovin MG, Coulthard P, Worthington HV. Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects. Cochrane Database Syst Rev 2005;19: CD003875.
4. Pontoriero R, Wennström J, Lindhe J. The use of barrier membranes and enamel matrix proteins in the treatment of angular bone defects. A prospective controlled clinical study. J Clin Periodontol 1999;26:833-840.
5. Sculean A, Windisch P, Chiantella GC, Donos N, Brecx M, Reich E. Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. A prospective controlled clinical study. J Clin Periodontol 2001;28:397-403. (Pubitemid 33755456)
6. Tonetti MS, Lang NP, Cortellini P, et al. Enamel matrix proteins in the regenerative therapy of deep intrabony defects. J Clin Periodontol 2002;29:317-325.
7. Trombelli L, Farina R. Clinical outcomes with bioactive agents alone or in combination with grafting or guided tissue regeneration. J Clin Periodontol 2008;35(Suppl. 8):117-135.
8. Cortellini P, Tonetti MS. A minimally invasive surgical technique with an enamel matrix derivative in the regenerative treatment of intra-bony defects: A novel approach to limit morbidity. J Clin Periodontol 2007; 34:87-93. (Pubitemid 44952524)
9. Harrel SK, Rees TD. Granulation tissue removal in routine and minimally invasive procedures. Compend Contin Educ Dent 1995;16:960-964, 962, 964 passim.
10. Takei H, Yamada H, Hau T. Maxillary anterior esthetics. Preservation of the interdental papilla. Dent Clin North Am 1989;33:263-273.
11. Cortellini P, Prato GP, Tonetti MS. The modified papilla preservation technique. A new surgical approach for interproximal regenerative procedures. J Periodontol 1995;66:261-266.
12. Cortellini P, Prato GP, Tonetti MS. The simplified papilla preservation flap. A novel surgical approach for the management of soft tissues in regenerative procedures. Int J Periodontics Restorative Dent 1999; 19:589-599.
13. Harrel SK, Wilson TG, Nunn ME. Prospective assessment of the use of enamel matrix proteins with minimally invasive surgery. J Periodontol 2005;76: 380-384. (Pubitemid 40668383)
14. Cortellini P, Tonetti MS. Minimally invasive surgical technique and enamel matrix derivative in intra-bony defects. I: Clinical outcomes and morbidity. J Clin Periodontol 2007;34:1082-1088.
15. Cortellini P, Nieri M, Prato GP, Tonetti MS. Single minimally invasive surgical technique with an enamel matrix derivative to treat multiple adjacent intra-bony defects: Clinical outcomes and patient morbidity. J Clin Periodontol 2008;35:605-613.
16. Ribeiro FV, Nociti Junior FH, Sallum EA, Sallum AW, Casati MZ. Use of enamel matrix protein derivative with minimally invasive surgical approach in intra-bony periodontal defects: Clinical and patient-centered outcomes. Braz Dent J 2010;21:60-67.
17. Harrel SK, Wilson TG Jr., Nunn ME. Prospective assessment of the use of enamel matrix derivative with minimally invasive surgery: 6-year results. J Periodontol 2010;81:435-441.
18. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
19. Ainamo J, Bay I. Problems and proposals for recording gingivitis and plaque. Int Dent J 1975;25: 229-235.
20. Mühlemann HR, Son S. Gingival sulcus bleeding - A leading symptom in initial gingivitis. Helv Odontol Acta 1971;15:107-113.
21. Persson GR, Falk H, Laurell L. A retrospective radiographic outcome assessment study of intra-bony defects treated by osseous surgery or by bone graft procedures. J Clin Periodontol 2000;27:104-108.
22. Piemontese M, Aspriello SD, Rubini C, Ferrante L, Procaccini M. Treatment of periodontal intrabony defects with demineralized freeze-dried bone allograft in combination with platelet-rich plasma: A comparative clinical trial. J Periodontol 2008;79:802-810.
23. Kalpidis CD, Ruben MP. Treatment of intrabony periodontal defects with enamel matrix derivative: A literature review. J Periodontol 2002;73:1360-1376. (Pubitemid 35469685)
24. Bokan I, Bill JS, Schlagenhauf U. Primary flap closure combined with Emdogain alone or Emdogain and Cerasorb in the treatment of intra-bony defects. J Clin Periodontol 2006;33:885-893. (Pubitemid 44715427)
25. Sanz M, Tonetti MS, Zabalegui I, et al. Treatment of intrabony defects with enamel matrix proteins or barrier membranes: Results from a multicenter practice-based clinical trial. J Periodontol 2004;75:726-733. (Pubitemid 38811864)
26. Tonetti MS, Pini-Prato G, Cortellini P. Periodontal regeneration of human intrabony defects. IV. Determinants of healing response. J Periodontol 1993;64:934-940.
27. Tsitoura E, Tucker R, Suvan J, Laurell L, Cortellini P, Tonetti M. Baseline radiographic defect angle of the intrabony defect as a prognostic indicator in regenerative periodontal surgery with enamel matrix derivative. J Clin Periodontol 2004;31:643-647. (Pubitemid 39092227)
28. Wachtel H, Schenk G, Böhm S, Weng D, Zuhr O, Hürzeler MB. Microsurgical access flap and enamel matrix derivative for the treatment of periodontal intrabony defects: A controlled clinical study. J Clin Periodontol 2003;30:496-504. (Pubitemid 38011178)
29. Froum SJ, Weinberg MA, Rosenberg E, Tarnow D. A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: A 12-month re-entry study. J Periodontol 2001;72:25-34. (Pubitemid 33607781)
30. Esposito M, Grusovin MG, Papanikolaou N, Coulthard P, Worthington HV. Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intra-bony defects. Cochrane Database Syst Rev 2009;7: CD003875.
31. Becker W, Becker BE, Ochsenbein C, et al. A longitudinal study comparing scaling, osseous surgery and modified Widman procedures. Results after one year. J Periodontol 1988;59:351-365.
32. Sipos PM, Loos BG, Abbas F, Timmerman MF, van der Velden U. The combined use of enamel matrix proteins and a tetracycline-coated expanded polytetrafluoroethylene barrier membrane in the treatment of intra-osseous defects. J Clin Periodontol 2005;32: 765-772. (Pubitemid 40923052)
33. Sculean A, Schwarz F, Chiantella GC, et al. Five-year results of a prospective, randomized, controlled study evaluating treatment of intra-bony defects with a natural bone mineral and GTR. J Clin Periodontol 2007; 34:72-77. (Pubitemid 44952522)
34. Fickl S, Thalmair T, Kebschull M, Böhm S, Wachtel H. Microsurgical access flap in conjunction with enamel matrix derivative for the treatment of intra-bony defects: A controlled clinical trial. J Clin Periodontol 2009;36:784-790.
35. Zetterström O, Andersson C, Eriksson L, et al. Clinical safety of enamel matrix derivative (EMDOGAIN) in the treatment of periodontal defects. J Clin Periodontol 1997;24:697-704. (Pubitemid 127731613)
36. Heijl L, Heden G, Svärdström G, Ostgren A. Enamel matrix derivative (EMDOGAIN) in the treatment of intrabony periodontal defects. J Clin Periodontol 1997; 24:705-714. (Pubitemid 127731614)
37. Kuru L, Griffiths GS, Petrie A, Olsen I. Changes in transforming growth factor-beta1 in gingival crevicular fluid following periodontal surgery. J Clin Periodontol 2004;31:527-533. (Pubitemid 38901222)
38. Schwartz Z, Carnes DL Jr., Pulliam R, et al. Porcine fetal enamel matrix derivative stimulates proliferation but not differentiation of pre-osteoblastic 2T9 cells, inhibits proliferation and stimulates differentiation of osteoblast-like MG63 cells, and increases proliferation and differentiation of normal human osteoblast NHOst cells. J Periodontol 2000;71:1287-1296.
39. Van der Pauw MT, Van den Bos T, Everts V, Beertsen W. Enamel matrix-derived protein stimulates attachment of periodontal ligament fibroblasts and enhances alkaline phosphatase activity and transforming growth factor beta1 release of periodontal ligament and gingival fibroblasts. J Periodontol 2000;71:31-43.
40. Okubo K, Kobayashi M, Takiguchi T, et al. Participation of endogenous IGF-I and TGF-beta 1 with enamel matrix derivative-stimulated cell growth in human periodontal ligament cells. J Periodontal Res 2003; 38:1-9. (Pubitemid 37463591)
41. Galli C, Macaluso GM, Guizzardi S, Vescovini R, Passeri M, Passeri G. Osteoprotegerin and receptor activator of nuclear factor-kappa B ligand modulation by enamel matrix derivative in human alveolar osteoblasts. J Periodontol 2006;77:1223-1228. (Pubitemid 44725030)
42. Lossdörfer S, Sun M, Götz W, Dard M, Jäger A. Enamel matrix derivative promotes human periodontal ligament cell differentiation and osteoprotegerin production in vitro. J Dent Res 2007;86: 980-985.
43. Lee AZ, Jiang J, He J, Safavi KE, Spangberg LS, Zhu Q. Stimulation of cytokines in osteoblasts cultured on enamel matrix derivative. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;106:133-138.
44. Ohyama M, Suzuki N, Yamaguchi Y, Maeno M, Otsuka K, Ito K. Effect of enamel matrix derivative on the differentiation of C2C12 cells. J Periodontol 2002;73: 543-550. (Pubitemid 34546407)
45. Tokiyasu Y, Takata T, Saygin E, Somerman M. Enamel factors regulate expression of genes associated with cementoblasts. J Periodontol 2000;71:1829-1839. (Pubitemid 33601020)